Bacillus amyloliquefaciens AP183 expresses secondary metabolites that inhibit the growth of methicillin-resistant Staphylococcus aureus (MRSA). Here, we present a ~3.99-Mbp draft genome sequence of AP183 with the aims of providing insights into the genomic basis of its antibacterial mechanisms and exploring its potential use in preventing MRSA skin colonization.

background during fishing and transport, preservation and quality of fish products are important as well as storage to prevent the growth of pathogenic and toxin producing bacteria. staphylococcus aureus is one of the most common causes of sea food-borne diseases worldwide due to contamination of food by preformed enterotoxins. the aim of this study was to compare the prevalence and contaminati...

b ackgro un d : staphylococcus aureus is a major human pathogen world wide. vancomycin has been used for decades to treat multidrug resistant s. aureus. ten years has passed since the first report of vancomycin re sistant s. aureus (vrsa). the objective of this systematic review was to determine  the total number of vrsa isolates that have been reported from iran. me t h ods :   search terms re...

conclusions high hvr diversity among the studied mrsa isolates could be a result of insufficient or inadequate infection-control protocols in tabriz hospitals. moreover, the high number of hvr genotypes showed that hvr typing can be used along with other typing methods in epidemiological studies of mrsa as a useful tool for monitoring, tracking contaminations, and controlling infections in hosp...

conclusions these results demonstrated that the recombinant lysostaphin produced in this study was able to kill nasal s. aureus in rats. it can be recommended for human clinical trial studies. results recombinant lysostaphin at 100 μg/ml concentration showed a significant decrease of the optical density compared to the control samples. the in vivo study demonstrated that a single dose (200 μg/d...

Infections with Staphylococcus aureus with reduced susceptibility to vancomycin continue to be reported, including 2 cases caused by S. aureus isolates with full resistance to vancomycin. This review first outlines the definitions of vancomycin-intermediate S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA) and risk factors for infection. Next, we describe the mechanisms of resistance a...

Methicillin-resistant S. aureus emerged in recent decades to become a leading cause of infection worldwide. Colonization with MRSA predisposes to infection and facilitates transmission of the pathogen; however, available regimens are ineffective at preventing MRSA colonization. Studies of human nasal flora suggest that resident bacteria play a critical role in limiting S. aureus growth, and pro...

We used several molecular typing methods to analyze 196 methicillin-resistant Staphylococcus aureus (MRSA) and 139 methicillin-susceptible S. aureus (MSSA) isolates collected between 1996 and 2005. The sequence type 72 MRSA has increased in frequency in the community in the Republic of Korea and in hospitals in recent years.

Frequencies at which mutants resistant to fusidic acid and/or rifampicin arose in vitro were determined in Staphylococcus aureus strains including methicillin-susceptible S. aureus (MSSA), methicillin-resistant S. aureus (MRSA), vancomycin-intermediate resistant S. aureus (VISA) and hetero-VISA. The concentrations of fusidic acid (30 and 15 mg/L) and rifampicin (16 and 1 mg/L) used for selectio...

Staphylococcus(S.) aureus produces different extra-cellular protein toxins and virulence factors. One of the most important extra-cellular proteins is an enterotoxin which causes staphylococcal food poisoning (SFP) due to their enterotoxins. Different methods have been used to detect this toxin, each of which has advantages and disadvantages. DNA amplification methods, however, can show the pre...